Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you use a Mirena coil and are considering tirzepatide, the straightforward answer is that the Mirena (a hormonal intrauterine device) is not affected by Mounjaro in the way oral contraceptives can be. NHS guidance specifically flags a concern about Mounjaro and hormonal contraception absorbed through the gut, because tirzepatide slows gastric emptying and may reduce how reliably a swallowed pill enters your bloodstream. The Mirena coil works locally in the womb and releases levonorgestrel directly into the uterine lining — it does not rely on absorption through the digestive system at all. That distinction matters, and it is why the guidance for the coil differs from the guidance for the pill. These are prescription-only medicines; a prescriber will review your full contraceptive and medical history before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The reason contraception comes up at all is rooted in how tirzepatide works. As a dual GIP and GLP-1 receptor agonist, it slows the rate at which food (and anything swallowed) moves through the stomach. For oral contraceptive pills, that slowing can affect absorption enough that the NHS advises women on Mounjaro to use an additional non-oral contraceptive method for the first four weeks of treatment and for four weeks after any dose increase. NHS England's guidance on weight-management injections sets this out clearly, and it applies specifically to tablets taken by mouth.
Intrauterine devices are a different category altogether. They are placed physically inside the uterus by a clinician and are not swallowed. The Mirena releases levonorgestrel directly into the uterine cavity at a very low, steady rate, thickening cervical mucus and thinning the womb lining. None of that process touches the gastrointestinal tract.
A common misconception is that because Mounjaro affects hormones (appetite hormones, specifically) it must somehow interfere with contraceptive hormones too. If you have found yourself wondering whether Mounjaro affects the coil, the short answer is that tirzepatide acts on GIP and GLP-1 receptors involved in appetite regulation and blood sugar and does not alter the metabolism or efficacy of levonorgestrel delivered locally by an IUD. The two mechanisms simply do not overlap in a clinically meaningful way.
NHS Scotland's guidance on diabetes and weight-loss medication, published on NHS Inform, addresses this distinction directly. The additional contraceptive precaution (using condoms or another barrier method during the early weeks) applies to oral (swallowed) hormonal contraceptives. Intrauterine devices, including hormonal ones like the Mirena, are not included in that precaution because their delivery mechanism is unaffected by changes in gastric motility.
The Mirena is also one of the most effective forms of contraception available, with a failure rate well below 1% per year under typical use. For anyone still uncertain, a closer look at whether Mounjaro stops the coil from working explains why its structural, locally acting efficacy is not something tirzepatide is expected to diminish.
None of this means the coil becomes invisible to your clinical assessment. Your prescriber needs to know your full contraceptive picture. If there is any uncertainty (for example, if you also take an oral pill alongside the coil, or if you are considering switching contraceptive methods) exploring whether Mounjaro affects the Mirena coil in detail with a clinician is the right step before starting treatment.
Transparency at consultation is the practical takeaway here. When you go through the Mounjaro treatment process, your prescriber will ask about your medical history, current medications and contraception. Listing the Mirena coil is straightforward; the prescriber can then confirm that no additional contraceptive precautions are needed for the coil itself.
If your circumstances are more complex (a recent coil fitting, plans to have it removed and try to conceive, or concurrent use of any oral hormonal preparation) those conversations need to happen before a prescription is issued, not after. Tirzepatide is not recommended during pregnancy or while trying to conceive, and a wash-out period applies; your prescriber will advise on timing based on your individual situation.
For a broader picture of how tirzepatide interacts with other aspects of daily life and medication, the Mounjaro FAQs page covers many of the questions our prescribers hear regularly. You can also read more about the clinical team and how consultations work on our about page. If cost is part of your thinking, the treatment overview page sets out what is included in a private prescription through nume, with no hidden charges. When you are ready, check your eligibility through a free consultation reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.